Rohto Pharmaceutical Co Ltd - Company Profile
Powered by 
All the data and insights you need on Rohto Pharmaceutical Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Rohto Pharmaceutical Co Ltd Strategy Report
- Understand Rohto Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
Rohto Pharmaceutical Co Ltd (Rohto Pharmaceutical) is engaged in manufacturing and marketing of pharmaceutical products, cosmetics and functional foods. The company offers products for eye care, skincare, internal medicine and other diseases. Under eyecare products, the company offers eye drops, contact lenses and eyewash. Under skincare products, the company offers face wash, creams, lotions, medicine and medicated products. It also offers medicines for internal use such as digestive products and herbal medicines. It has manufacturing and research laboratories in Iga, Osaka and Kyoto. The company along with its subsidiaries operates across the Americas, Asia, Japan, Oceania, Africa and Europe. Rohto Pharmaceutical is headquartered in Osaka, Japan.
Headquarters
Japan
Address
1-8-1, Tatsumi-Nishi, Ikuno-Ku, Osaka-Shi, 544-8666
Website
www.rohto.co.jp
Telephone
81 6 67581231
No of Employees
7,176
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
4527 (TYO)
Revenue (2022)
$1.8B
19.5%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
24.8%
(2022 vs 2021)
Market Cap*
$4.4B
Net Profit Margin (2022)
XYZ
4.4%
(2022 vs 2021)
* As of and is in US$
Rohto Pharmaceutical Co Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Eye Care | Auna |
| Eye Drops | Skio |
| Eye Wash Preparations | Rohto V5 Grain |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Plans/Strategy | In April, the company and Mitsui & Co announced their plans to acquire an 86% stake in Eu Yan Sang International Ltd for US$594 million. |
| 2024 | New Products/Services | In March, the company introduced Rohto Rise Glow. |
| 2024 | New Products/Services | In February, the company introduced Hyaluronic Mist UV. |
Competitor Comparison
| Key Parameters | Rohto Pharmaceutical Co Ltd | Daiichi Sankyo Co Ltd | Chugai Pharmaceutical Co Ltd | Shionogi & Co Ltd | Taisho Pharmaceutical Holdings Co Ltd |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | Japan | Japan | Japan |
| City | Osaka-Shi | Chuo-Ku | Chuo-Ku | Osaka-Shi | Toshima-Ku |
| State/Province | Osaka | Tokyo | Tokyo | Osaka | Tokyo |
| No. of Employees | 7,176 | 17,435 | 7,771 | 5,680 | 8,784 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Kunio Yamada | Chairman; Chief Executive Officer | Executive Board | - | - |
| Masaya Saito | Director; Chief Financial Officer; Executive Vice President | Executive Board | - | - |
| Masashi Sugimoto | Chief Operating Officer; Director; President | Executive Board | - | - |
| Atsushi Hiyama | Chief Communications Officer; Director | Executive Board | - | - |
| Shinichi Kunisaki | Director; Chief Technical Officer | Executive Board | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward